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Background:  Retrospective data have shown that selective intracoronary administration of Nitroprusside prior to percutaneous coronary 
intervention (PCI) is safe, prevents no or slow reflows, and improves reperfusion of the infarcted myocardium for acute myocardial infarction (AMI) . 
There is paucity of prospective data regarding the usefulness of this therapy which we analysed.
Methods:  We randomly assigned 87 consecutive patients with AMI to perform PCI with Nitroprusside ( 44 patients) or with Nitroglycerine( 43 
patients).Nitroglycerine(200μg) & Nitroprusside (120 μg) was selectively administered through the drug delivery catheter into the distal coronary 
artery to reach the target lesion before balloon dilatation. Clinical and angiographic data, as well as in-hospital outcomes, of Nitroprusside group 
were compared with Nitroglycerine group.
Results:  There were no significant differences in the baseline characteristics between the 2 groups. Compared to the Nitroglycerine group, 
the Nitroprusside group had less slow reflow during the procedure (19% vs. 36%, p=0.0442); a similar final TIMI flow grade (III:II:I:0 = 31:2:1:0 
vs. 29:4:2:0, p=0.5524); a better blush grade (III:II:I:0 = 28:5:1:0 vs. 20:8:5:2, p=0.0483); and a better corrected TIMI coronary frame count 
(31.1±10.0 vs. 45.1±20.1, p=0.0008). There were no particular complications with Nitroprusside use.
Conclusions:  The selective intracoronary administration of Nitroprusside prior to PCI is safe and well tolerated, prevents no or slow reflows, and 
improves reperfusion of the infarcted myocardium in AMI
